Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
December 12, 2016
The article describes how innovative technology developed by FDNA allows for identifying genetic diseases through a simple selfie. Using advanced facial recognition algorithms, this tool can analyze facial features and detect markers associated with various genetic disorders. This groundbreaking method is designed to support healthcare professionals in making quicker and more accurate diagnoses, potentially transforming the genetic screening process. By integrating AI with genetic research, FDNA’s approach leverages everyday technology to offer a non-invasive, accessible, and efficient solution for the early identification of genetic diseases, paving the way for improved patient outcomes and personalized healthcare strategies.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…